Healio

Chemosensitivity may predict PFS after first-line treatment in ovarian cancer

Please provide your email address to receive an email when new articles are posted on . KELIM, a model-based parameter from CA-125 kinetics, was an independent prognostic factor of progression-free ...
Seeking Alpha

PFS Provident Financial Services, Inc.

Provident Financial Services, Inc. (PFS) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions ...
Yahoo Finance

AVEO Oncology to Present Positive New Long-Term PFS Data from Phase 3 TIVO-3 Study of FOTIVDA® (tivozanib) in Third- and Fourth-Line Renal Cell Carcinoma

BOSTON, Feb. 14, 2022 (GLOBE NEWSWIRE) -- AVEO Oncology (Nasdaq: AVEO), a commercial stage, oncology-focused biopharmaceutical company, today announced that new long-term progression free survival ...
ascopubs.org

Progression-free survival (PFS) with maintenance treatment with bevacizumab (B) in patients with responding mCRC after first-line chemotherapy (CT) plus B.

Phase II study of S-1, oral leucovorin, oxaliplatin, and bevacizumab combination therapy (SOL+BV; SOLA) in patients with unresectable metastatic colorectal cancer (mCRC). Background: Maintenance ...
ascopubs.org

Use of serum uPA change to predict PFS and overall survival in first-line trastuzumab-treated breast cancer.

Open-label, multicenter, phase Ib, dose-escalation study of oral lapatinib (L) in combination with docetaxel (D) and trastuzumab (T) in untreated HER2-overexpressing (HER+) metastatic breast cancer ...